Form 13F-NT - Quarterly report filed by institutional managers, Notice:
SEC Accession No. 0000950123-22-006417
Filing Date
2022-05-16
Accepted
2022-05-16 16:01:40
Documents
1
Period of Report
2022-03-31
Effectiveness Date
2022-05-16

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 13F-NT  
1 primary_doc.xml 13F-NT 2161
  Complete submission text file 0000950123-22-006417.txt   3215
Mailing Address 200 CLARENDON STREET BOSTON MA 02116
Business Address 200 CLARENDON STREET BOSTON MA 02116 617-516-2000
Bain Capital Life Sciences Investors II, LLC (Filer) CIK: 0001796155 (see all company filings)

EIN.: 981481394 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 13F-NT | Act: 34 | File No.: 028-20816 | Film No.: 22928532